First Time Loading...

Aveo Pharmaceuticals Inc
NASDAQ:AVEO

Watchlist Manager
Aveo Pharmaceuticals Inc Logo
Aveo Pharmaceuticals Inc
NASDAQ:AVEO
Watchlist
Price: 15 USD Market Closed
Updated: May 29, 2024

Aveo Pharmaceuticals Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aveo Pharmaceuticals Inc
Total Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Aveo Pharmaceuticals Inc
NASDAQ:AVEO
Total Assets
$101.2m
CAGR 3-Years
19%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Assets
$148.9B
CAGR 3-Years
0%
CAGR 5-Years
21%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Total Assets
$56.3B
CAGR 3-Years
-6%
CAGR 5-Years
-2%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Total Assets
$93B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Assets
$23.9B
CAGR 3-Years
25%
CAGR 5-Years
30%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Assets
$34.4B
CAGR 3-Years
25%
CAGR 5-Years
22%
CAGR 10-Years
27%

See Also

What is Aveo Pharmaceuticals Inc's Total Assets?
Total Assets
101.2m USD

Based on the financial report for Sep 30, 2022, Aveo Pharmaceuticals Inc's Total Assets amounts to 101.2m USD.

What is Aveo Pharmaceuticals Inc's Total Assets growth rate?
Total Assets CAGR 5Y
19%

Over the last year, the Total Assets growth was -7%. The average annual Total Assets growth rates for Aveo Pharmaceuticals Inc have been 19% over the past three years , 19% over the past five years .